BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16585864)

  • 1. Lidocaine block of the recurrent laryngeal nerve in adductor spasmodic dysphonia: a multidimensional assessment.
    Smith ME; Roy N; Wilson C
    Laryngoscope; 2006 Apr; 116(4):591-5. PubMed ID: 16585864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adductor spasmodic dysphonia versus muscle tension dysphonia: examining the diagnostic value of recurrent laryngeal nerve lidocaine block.
    Roy N; Smith ME; Allen B; Merrill RM
    Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):161-8. PubMed ID: 17419518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the phonatory effects of external superior laryngeal nerve paralysis: an in vivo model.
    Roy N; Smith ME; Dromey C; Redd J; Neff S; Grennan D
    Laryngoscope; 2009 Apr; 119(4):816-26. PubMed ID: 19266586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of adductor spasmodic dysphonia and muscle tension dysphonia using phonatory break analysis.
    Roy N; Whitchurch M; Merrill RM; Houtz D; Smith ME
    Laryngoscope; 2008 Dec; 118(12):2245-53. PubMed ID: 19029863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward improved differential diagnosis of adductor spasmodic dysphonia and muscle tension dysphonia.
    Roy N; Mauszycki SC; Merrill RM; Gouse M; Smith ME
    Folia Phoniatr Logop; 2007; 59(2):83-90. PubMed ID: 17337898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome.
    Su CY; Lai CC; Wu PY; Huang HH
    Laryngoscope; 2010 Feb; 120(2):313-8. PubMed ID: 20013850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laryngeal reinnervation with the hypoglossal nerve: II. Clinical evaluation and early patient experience.
    Paniello RC
    Laryngoscope; 2000 May; 110(5 Pt 1):739-48. PubMed ID: 10807353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia.
    Chhetri DK; Mendelsohn AH; Blumin JH; Berke GS
    Laryngoscope; 2006 Apr; 116(4):635-42. PubMed ID: 16585872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of ansa to recurrent laryngeal nerve reinnervation.
    Lee WT; Milstein C; Hicks D; Akst LM; Esclamado RM
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):450-4. PubMed ID: 17321876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laryngeal reinnervation for unilateral recurrent laryngeal nerve injuries caused by thyroid surgery].
    Zheng H; Zhou S; Chen S; Li Z; Huang Y; Zhang S; Wen W; Cui Y; Shen X; Liu F
    Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(15):1042-5. PubMed ID: 12194795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Task specificity in adductor spasmodic dysphonia versus muscle tension dysphonia.
    Roy N; Gouse M; Mauszycki SC; Merrill RM; Smith ME
    Laryngoscope; 2005 Feb; 115(2):311-6. PubMed ID: 15689757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ansa-RLN reinnervation for unilateral vocal fold paralysis in adolescents and young adults.
    Smith ME; Roy N; Stoddard K
    Int J Pediatr Otorhinolaryngol; 2008 Sep; 72(9):1311-6. PubMed ID: 18586331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptual analyses of spasmodic dysphonia before and after treatment.
    Cannito MP; Woodson GE; Murry T; Bender B
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predicting patient perception of dysphonia caused by benign vocal fold lesions.
    Behrman A; Sulica L; He T
    Laryngoscope; 2004 Oct; 114(10):1693-700. PubMed ID: 15454756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of Parkinson's-related dysphonia.
    Sewall GK; Jiang J; Ford CN
    Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listening: the key to diagnosing spasmodic dysphonia.
    Braden MN; Hapner ER
    ORL Head Neck Nurs; 2008; 26(1):8-12. PubMed ID: 18274236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
    Zwirner P; Murry T; Swenson M; Woodson GE
    Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voice handicap index results for older patients with adductor spasmodic dysphonia.
    Wingate JM; Ruddy BH; Lundy DS; Lehman J; Casiano R; Collins SP; Woodson GE; Sapienza C
    J Voice; 2005 Mar; 19(1):124-31. PubMed ID: 15766857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
    Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
    J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.